Loading clinical trials...
Loading clinical trials...
The purpose of this study was to study the effect of stem cell therapy on the course of the disease in patients with Limb Girdle Muscular Dystrophy.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Neurogen Brain and Spine Institute
NCT05876780 · Limb Girdle Muscular Dystrophy
NCT05206617 · Neuromuscular Diseases, Limb Girdle Muscular Dystrophy
NCT03981289 · Limb Girdle Muscular Dystrophy, Muscular Dystrophies
NCT05906251 · Limb Girdle Muscular Dystrophy
NCT06747273 · Limb Girdle Muscular Dystrophy, Limb Girdle Muscular Dystrophy Type 2D/R3
Neurogen brain and spine institute
Mumbai, Maharashtra
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions